Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1002/jcp.25676 http://scihub22266oqcxt.onion/10.1002/jcp.25676 C5347962!5347962 !27808423     free     free     free Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\27808423 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       J+Cell+Physiol 2017 ; 232 (6 ): 1233-1238 Nephropedia Template TP {{tp|p=27808423 |t=2017. The Emerging Role of TRAF7 in Tumor Development |pdf=|usr=}}{{27808423 }} gab.com Text The Emerging Role of TRAF7 in Tumor Development JO: J Cell Physiol http://www.kidney.de/pget.php?&tw=1&pmid=27808423 #FOAvip The seven members of the tumor necrosis factor receptor (TNF-R)-associated factor (TRAF) family of intracellular proteins were originally discovered and characterized as signaling adaptor molecules coupled to the cytoplasmic regions of receptors of the TNF-R superfamily. Functionally, TRAFs act both as a scaffold and/or enzymatic proteins to regulate activation of mitogen-activated protein kinases (MAPKs) and transcription factors of nuclear factor-?B family (NF-?B). Given the wide variety of stimuli intracellularly conveyed by TRAF proteins, they are physiologically involved in multiple biological processes, including embryonic development, tissue homeostasis, and regulation of innate and adaptive immune responses. In the last few years, it has become increasingly evident the involvement of TRAF7, the last member of the TRAF family to be discovered, in the genesis and progression of several human cancers, placing TRAF7 in the spotlight as a novel tumor suppressor protein. In this paper, we review and discuss the literature recently produced on this subject. J. Cell. Physiol. 232: 1233-1238, 2017. © 2016 The Authors. Journal of Cellular Physiology Published by Wiley Periodicals, Inc. Twit Text FOAVip The Emerging Role of TRAF7 in Tumor Development ????J Cell Physiol http://www.kidney.de/pget.php?&tw=1&pmid=27808423 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=27808423 #FOAvip English Wikipedia <ref>{{Cite pmid|27808423 }}</ref> The Emerging Role of TRAF7 in Tumor Development #MMPMID27808423 Zotti T ; Scudiero I ; Vito P ; Stilo R J Cell Physiol 2017[Jun]; 232 (6 ): 1233-1238 PMID27808423 show ga The seven members of the tumor necrosis factor receptor (TNF-R)-associated factor (TRAF) family of intracellular proteins were originally discovered and characterized as signaling adaptor molecules coupled to the cytoplasmic regions of receptors of the TNF-R superfamily. Functionally, TRAFs act both as a scaffold and/or enzymatic proteins to regulate activation of mitogen-activated protein kinases (MAPKs) and transcription factors of nuclear factor-?B family (NF-?B). Given the wide variety of stimuli intracellularly conveyed by TRAF proteins, they are physiologically involved in multiple biological processes, including embryonic development, tissue homeostasis, and regulation of innate and adaptive immune responses. In the last few years, it has become increasingly evident the involvement of TRAF7, the last member of the TRAF family to be discovered, in the genesis and progression of several human cancers, placing TRAF7 in the spotlight as a novel tumor suppressor protein. In this paper, we review and discuss the literature recently produced on this subject. J. Cell. Physiol. 232: 1233-1238, 2017. © 2016 The Authors. Journal of Cellular Physiology Published by Wiley Periodicals, Inc. |Animals [MESH] |Carcinogenesis/*metabolism/*pathology [MESH] |Humans [MESH] |Models, Biological [MESH] |Mutation/genetics [MESH] |Neoplasms/*metabolism/*pathology [MESH] |Protein Domains [MESH]The Emerging Role of TRAF7 in Tumor Development (epmc).pdf DeepDyve Pubget Overpricing